7 Common Mistakes With Antidepressants

Slideshow

Drug interactions, discontinuation issues, adverse effects, and more. These are the problems that are often overlooked.

Related Videos
Experts on MDD.
Experts on MDD.
Related Content

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

The Week in Review: September 18-22

September 23rd 2023

Phase 3 Study Supports Efficacy, Safety of New Chemical Entity for MDD

September 20th 2023

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

The Week in Review: September 18-22

September 23rd 2023

Phase 3 Study Supports Efficacy, Safety of New Chemical Entity for MDD

September 20th 2023

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

The Week in Review: September 18-22

September 23rd 2023

Phase 3 Study Supports Efficacy, Safety of New Chemical Entity for MDD

September 20th 2023
© 2023 MJH Life Sciences

All rights reserved.